The hottest Clinical Trials Substack posts right now

And their main takeaways
Category
Top Health & Wellness Topics
Ground Truths 15222 implied HN points 19 Jan 24
  1. A new study on Long Covid analyzed 6,600 proteins to identify potential biomarkers like complement activation.
  2. Vaccination offers substantial protection against Long Covid, especially in those not at risk of severe illness.
  3. Recent reports highlight potential neurologic damage from Covid and call for more research on effective treatments.
Pierre Kory’s Medical Musings 4835 implied HN points 28 Jan 24
  1. Dr. Hoffe advocates for the safety and effectiveness of ivermectin as a Covid treatment.
  2. Extensive data supports the unparalleled safety profile of ivermectin for Covid and parasitic diseases.
  3. Comparisons show that ivermectin is safer than other approved Covid treatments like Remdesivir, Paxlovid, and Molnupiravir.
Alexander News Network -Dr. Paul Elias Alexander's substack 1572 implied HN points 25 Jan 24
  1. Forensic analysis found a 3.7-fold increase in deaths due to cardiovascular events in Pfizer vaccinated individuals compared to placebo.
  2. The adverse event signal was not reported by Pfizer/BioNTech.
  3. Inconsistencies were found in subject data reported in the study and publications by Pfizer/BioNTech trial site administrators.
Trevor Klee’s Newsletter 1119 implied HN points 05 Feb 24
  1. Karuna Therapeutics achieved a $14 billion sale through drug repurposing.
  2. Drug repurposing can be a highly lucrative business without requiring excessive brilliance or luck.
  3. VCs often prioritize hype and platform-based drug development over drug repurposing success stories.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
Rory’s Always On Newsletter 530 implied HN points 07 Feb 24
  1. AI and machine learning are revolutionizing drug discovery by speeding up the identification of potential treatments, leading to big rewards for those in the industry.
  2. Building a successful biotech company requires patience, determination, and significant funding, often with a focus on research and development before revenue generation.
  3. Investors in biotech companies must be prepared for a long journey of constant failures and successes, akin to the process of drug discovery, with potential acquisitions being key outcomes.
The Last Bear Standing 43 implied HN points 15 Mar 24
  1. There has been a resurgence of interest in the medical potential of psychedelics, with ongoing research and clinical trials exploring their efficacy in treating mental health conditions.
  2. Despite the challenges and market fluctuations, there is increasing regulatory support for psychedelic drug trials, potentially leading to FDA approvals and breakthrough therapy designations for conditions like PTSD.
  3. Psychedelic treatments involve controlled drug administration in conjunction with therapy, aiming to address the root causes of mental health disorders by stimulating new perspectives and thought patterns.
Rory’s Always On Newsletter 727 implied HN points 05 Sep 23
  1. Professor Sonia Gandhi leads a mission to improve Parkinson's trials by implementing ACT PD initiative for more efficient drug testing.
  2. The UK aims to become a hub for clinical trials like the multi-arm system to find disease-modifying therapies for Parkinson's faster.
  3. Funding is crucial for scientists like Professor Gandhi to advance technology and trial designs for breakthroughs in Parkinson's research.
The Century of Biology 308 implied HN points 30 Jul 23
  1. Vial is working to reduce the cost of clinical trials by innovating new technology.
  2. Vial's Act I focuses on structuring, digitizing, and automating the clinical trial process to drive efficiency.
  3. Vial's Act II, Battery Bio, aims to revolutionize drug discovery by integrating software and advanced technologies in a vertically integrated approach.
Who is Robert Malone 15 implied HN points 06 Mar 24
  1. Claims about COVID-19 vaccines' effectiveness and safety were exaggerated in clinical trials and observational studies, impacting risk-benefit analyses.
  2. Observational studies exhibited biases like case-counting window bias, affecting estimates of vaccine effectiveness.
  3. Studies showed issues with safety estimates, short counting windows, and potential negative effectiveness of COVID-19 vaccines.
Injecting Freedom 137 implied HN points 03 Aug 23
  1. Dr. Paul Offit's article raises concerns about vaccine clinical trials and the lack of placebo controls.
  2. There is a debate about the safety and efficacy of childhood vaccines and the importance of proper clinical trials.
  3. The ethical considerations of vaccine trials and the need for valid safety profiles are highlighted.
Axial 7 implied HN points 17 Feb 24
  1. MoonLake Immunotherapeutics is developing a tri-specific nanobody therapy called Sonelokimab (SLK) that has shown significant efficacy in treating inflammatory diseases like HS, PsA, and PsO.
  2. SLK offers unique benefits like blocking all IL-17 pro-inflammatory dimers, enabling tissue penetration, and maintaining high response rates in patients with moderate-to-severe conditions.
  3. MoonLake's SLK has the potential to become a best-in-class IL-17 inhibitor in a multibillion-dollar market, with its innovative structure, clinical success, and competitive advantages over existing treatments.
Injecting Freedom 80 implied HN points 25 Jun 23
  1. Most childhood vaccines were licensed without using a placebo control in their clinical trials.
  2. The clinical trial for RotaTeq did not use a true placebo as the control group, but included bioactive ingredients.
  3. Robert F. Kennedy, Jr. advocates for vaccine safety and freedom of choice without restricting access to vaccines.
Superfluid 26 implied HN points 19 Apr 23
  1. Clinical trials are expensive and crucial for determining the efficacy and safety of new drugs.
  2. There are multiple stakeholders involved in running a clinical trial, each with important roles to play.
  3. Challenges in clinical trials include patient recruitment, trial logistics, and data analytics, but there are innovative startups working on solutions.
Discovery by Axial 1 implied HN point 08 Sep 23
  1. Clinical trial statistical analysis involves collecting and interpreting data to evaluate new treatments.
  2. Startups have opportunities to develop software for automating and streamlining statistical analysis processes due to increasing data complexity.
  3. Software development for data integration, visualization, and communication can improve efficiency in clinical trial statistical analysis.